Symphogen Announces the Appointment of Annika Espander Jansson as Non-Executive Director

Symphogen Announces the AppointmentSymphogen Announces the Appointment of Annika Espander Jansson as Non- Executive Director PR Newswire COPENHAGEN, Denmark, December 20, 2013 Symphogen A/S, a private biopharmaceutical company with leadership in recombinant antibody mixtures for therapeutic use, today announces the appointment of Annika Espander Jansson as a Non-Executive Director of the Board